• LinkedIn

The Business of Biofabrication

  • News
  • Perspectives
  • Learn

R.D. Solorzano

  • Humacyte Reports Positive Data on Bioengineered Vessels for Vascular Repair and Coronary Bypass
    September 22, 2025

    Humacyte Reports Positive Data on Bioengineered Vessels for Vascular Repair and Coronary Bypass

    R.D. Solorzano
  • eGenesis Wins FDA Green Light for Gene-Edited Pig Kidney Trial
    September 22, 2025

    eGenesis Wins FDA Green Light for Gene-Edited Pig Kidney Trial

    R.D. Solorzano
  • Tel Aviv University and Matricelf Poised for First-in-Human Spinal Cord Implant
    September 12, 2025

    Tel Aviv University and Matricelf Poised for First-in-Human Spinal Cord Implant

    R.D. Solorzano
  • Terumo Acquires OrganOx for $1.5 Billion: A Landmark Deal in Organ Preservation and Transplantation
    August 25, 2025

    Terumo Acquires OrganOx for $1.5 Billion: A Landmark Deal in Organ Preservation and Transplantation

    R.D. Solorzano
  • Instant Collagen, Real-Time Biofabrication: What TRACE Means for the Lab & the Market
    August 8, 2025

    Instant Collagen, Real-Time Biofabrication: What TRACE Means for the Lab & the Market

    R.D. Solorzano
  • TISSIUM’s COAPTIUM Connect ushers in photopolymer 3‑D printing for implantables
    July 23, 2025

    TISSIUM’s COAPTIUM Connect ushers in photopolymer 3‑D printing for implantables

    R.D. Solorzano
  • Xeltis Reports Positive 24-Month Clinical Success for Regenerative CABG Conduit
    July 18, 2025

    Xeltis Reports Positive 24-Month Clinical Success for Regenerative CABG Conduit

    R.D. Solorzano
  • Aspect Biosystems Showcases Bioprinted Adrenal Tissue Data at ENDO 2025
    July 17, 2025

    Aspect Biosystems Showcases Bioprinted Adrenal Tissue Data at ENDO 2025

    R.D. Solorzano
  • CollPlant Expands U.S. Footprint with Strategic Hire to Lead Commercial GrowthBusiness of Biofabrication
    July 16, 2025

    CollPlant Expands U.S. Footprint with Strategic Hire to Lead Commercial GrowthBusiness of Biofabrication

    R.D. Solorzano
  • Nanochon Receives Green Light from Health Canada for First-in-Human Trial of 3D-Printed Chondrograft™ Implant
    July 13, 2025

    Nanochon Receives Green Light from Health Canada for First-in-Human Trial of 3D-Printed Chondrograft™ Implant

    R.D. Solorzano
Previous Page
1 2 3 4 5 … 12
Next Page

Archives

To make sense of, stay update on, and learn about
the business of biofabrication

Subscribe

2024 All Rights Reserved

  • Subscribe Subscribed
    • The Business of Biofabrication
    • Already have a WordPress.com account? Log in now.
    • The Business of Biofabrication
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar